Nymox Pharmaceutical
NYMX
#8001
Rank
$18.25 M
Marketcap
Bahamas
Country
$0.20
Share price
0.00%
Change (1 day)
-56.52%
Change (1 year)
Categories
Nymox Pharmaceutical (NYMX) - Net assets
Net assets on the balance sheet as of June 2023 : -$2.88 M
According to Nymox Pharmaceutical's latest financial reports the company has -$2.88 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Nymox Pharmaceutical - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $-0.49 M | -4.74% |
| 2021-12-31 | $-0.51 M | -123.59% |
| 2020-12-31 | $2.14 M | -37.79% |
| 2019-12-31 | $3.44 M | -50.76% |
| 2018-12-31 | $7 M | -659.71% |
| 2017-12-31 | $-1.26 M | 95.04% |
| 2016-12-31 | $-0.65 M | -76.7% |
| 2015-12-31 | $-2.76 M | -34.15% |
| 2014-12-31 | $-4.19 M | -30.99% |
| 2013-12-31 | $-6.06 M | -18.62% |
| 2012-12-31 | $-7.45 M | 43.23% |
| 2011-12-31 | $-5.2 M | 82.08% |
| 2010-12-31 | $-2.86 M | 96.58% |
| 2009-12-31 | $-1.46 M | -151.67% |
| 2008-12-31 | $2.81 M | -5.22% |
| 2007-12-31 | $2.96 M | 62.36% |
| 2006-12-31 | $1.82 M | 50.69% |
| 2005-12-31 | $1.21 M | -39.77% |
| 2004-12-31 | $2.01 M | -16.1% |
| 2003-12-31 | $2.39 M | -16.92% |
| 2002-12-31 | $2.88 M | -16.19% |
| 2001-12-31 | $3.44 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | -2,390,576.19% | 🇺🇸 USA |
 Pfizer PFE | $89.28 B | -3,103,610.60% | 🇺🇸 USA |
 Abbott Laboratories ABT | $38.82 B | -1,349,665.52% | 🇺🇸 USA |
 Eli Lilly LLY | $10.86 B | -377,705.14% | 🇺🇸 USA |
 Quest Diagnostics
DGX | $6.41 B | -223,179.60% | 🇺🇸 USA |